This is a study to develop methods of diagnosing chronic traumatic encephalopathy (CTE) during life, as well as to examine possible risk factors for this neurodegenerative disease. One component of this study is the use of an investigational PET scan radio tracer to detect abnormal tau protein in the brain.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Neuroimaging Positron Emission Tomography for Amyloid Biomarker
Timeframe: One-Time
Fluid Biomarkers
Timeframe: 3 Years
Neuropsychiatric and Neurocognitive Tests
Timeframe: 3 years
Neurological Evaluation
Timeframe: 3 years
Magnetic Resonance Imagining Biomarkers
Timeframe: 3 years
Neuroimaging Positron Emission Tomography for Tau Biomarker
Timeframe: 3 years
Magnetic Resonance Spectroscopy Biomarkers
Timeframe: 3 years